BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 32 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,359,000 | -82.7% | 1,359,000 | -77.2% | 0.04% | -84.0% |
| Q2 2020 | $7,862,000 | +4.1% | 5,961,000 | -16.3% | 0.25% | -6.4% |
| Q1 2020 | $7,553,000 | -2.1% | 7,121,000 | 0.0% | 0.27% | +21.9% |
| Q4 2019 | $7,718,000 | +30.9% | 7,121,000 | +24.5% | 0.22% | +21.7% |
| Q3 2019 | $5,896,000 | +40.7% | 5,721,000 | +53.7% | 0.18% | +39.5% |
| Q2 2019 | $4,189,000 | -1.5% | 3,721,000 | 0.0% | 0.13% | -5.8% |
| Q1 2019 | $4,254,000 | +17.7% | 3,721,000 | +15.5% | 0.14% | +3.8% |
| Q4 2018 | $3,613,000 | -6.7% | 3,221,000 | -0.6% | 0.13% | +23.4% |
| Q3 2018 | $3,873,000 | +1.0% | 3,239,000 | 0.0% | 0.11% | -3.6% |
| Q2 2018 | $3,834,000 | +9.0% | 3,239,000 | +1.6% | 0.11% | -6.7% |
| Q1 2018 | $3,519,000 | -6.9% | 3,189,000 | 0.0% | 0.12% | -7.0% |
| Q4 2017 | $3,779,000 | -1.7% | 3,189,000 | 0.0% | 0.13% | -6.6% |
| Q3 2017 | $3,843,000 | +47.1% | 3,189,000 | +45.7% | 0.14% | +39.8% |
| Q2 2017 | $2,613,000 | +0.2% | 2,189,000 | 0.0% | 0.10% | -2.0% |
| Q1 2017 | $2,609,000 | +1.1% | 2,189,000 | 0.0% | 0.10% | +3.1% |
| Q4 2016 | $2,581,000 | -6.0% | 2,189,000 | -0.3% | 0.10% | -1.0% |
| Q3 2016 | $2,747,000 | +2.5% | 2,195,000 | -5.3% | 0.10% | +1.0% |
| Q2 2016 | $2,681,000 | -2.5% | 2,317,000 | 0.0% | 0.10% | +7.8% |
| Q1 2016 | $2,749,000 | -6.6% | 2,317,000 | +5.4% | 0.09% | -6.2% |
| Q4 2015 | $2,942,000 | -5.8% | 2,199,000 | -5.0% | 0.10% | +4.3% |
| Q3 2015 | $3,124,000 | -5.8% | 2,315,000 | +11.6% | 0.09% | +9.5% |
| Q2 2015 | $3,318,000 | +6.1% | 2,075,000 | 0.0% | 0.08% | +6.3% |
| Q1 2015 | $3,128,000 | +23.5% | 2,075,000 | 0.0% | 0.08% | +29.5% |
| Q4 2014 | $2,532,000 | +10.8% | 2,075,000 | 0.0% | 0.06% | +5.2% |
| Q3 2014 | $2,286,000 | +4.3% | 2,075,000 | 0.0% | 0.06% | +9.4% |
| Q2 2014 | $2,192,000 | -4.8% | 2,075,000 | +0.3% | 0.05% | -5.4% |
| Q1 2014 | $2,303,000 | +0.4% | 2,069,000 | -2.8% | 0.06% | -6.7% |
| Q4 2013 | $2,293,000 | – | 2,128,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|